Clinical Trial Update: Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Knee Replacement. [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing oral tranexamic acid to oral aminocaproic acid to reduce blood loss and transfusion after total knee replacement has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Aminocaproic acid (oral) (aminocaproic acid)
• Tranexamic acid (oral) (tranexamic acid)

Snippet

Sponsor: Universidad Autonoma de Nuevo Leon | Conditions: Knee Osteoarthritis, Blood Clot | Phase 2 | Status: COMPLETED